Developer docs
API playgroundTry for free, no card

Search company profiles

Ciap Citologia E Anatomia Patologica

Full company profile

uuid004r5s4

Namestring
Ciap Citologia E Anatomia Patologica
Legal namestring
Laboratório CIAP – Citologia e Anatomia Patológica
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Laboratório CIAP – Citologia e Anatomia Patológica is a private, founder-led clinical pathology laboratory headquartered in Divinópolis, Minas Gerais, Brazil. Founded in 2015, it operates as the principal reference laboratory for pathological anatomy and cytology in the Centro-Oeste region of Minas Gerais, serving private patients, patients covered by 19 health insurance plans (including Unimed, Bradesco Saúde, and Cemig Saúde), and hospitalized patients funded through the Brazilian public healthcare system (SUS). Services are delivered from a main location on Av. Getúlio Vargas in Divinópolis and a fixed collection point at Hospital São João de Deus.

The laboratory's diagnostic portfolio spans cytopathology (Papanicolau and oncotic cytology), anatomical pathology on surgical specimens and biopsies, immunohistochemistry for tumor classification, in situ hybridization (HIS) for viral detection (HPV, EBV), chromosomal damage analysis and HER2/neu verification, intraoperative frozen section for real-time surgical guidance, and — as of February 2025 — PCR-based HPV genotyping covering up to 15 high-risk genotypes from a single liquid-based sample compatible with the GynoPrep collection kit. Quality assurance is anchored by ONA "Acreditado" certification (evaluated by DNV under Brazilian Accreditation Manual Version 2018 and Norma NA 4), participation in the PICQ quality control program of the Sociedade Brasileira de Patologia, and SBP-certified specialist pathologists trained at UNIFESP, Hospital A.C. Camargo, and Sírio Libanês.

Revenue is generated on a fee-per-examination basis across the three payer channels (private, convênio, SUS), with pricing not publicly disclosed. Patient report delivery is handled through the third-party Laudos Med platform. The business is governed under a formal structure compliant with Brazil's LGPD, with a designated Data Protection Officer. There is no evidence of external investment, multi-site operations, or expansion beyond the Centro-Oeste region of Minas Gerais.

Short descriptiontext

Laboratório CIAP is a private clinical pathology laboratory in Divinópolis, Minas Gerais, Brazil, providing cytology, anatomical pathology, immunohistochemistry, in situ hybridization, frozen section, and HPV PCR genotyping to private patients, 19+ health insurers, and SUS across the Centro-Oeste region of Minas Gerais.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDivinópolis, Brazil
HQ citystring
Divinópolis
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostic pathology services, cytopathology laboratory, anatomical pathology, immunohistochemistry testing, HPV genotyping PCR
Industry1 code
1Anatomic Pathology (Histopathology & Cytopathology)
CodeHLAFAMAAPrimaryYes
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Diagnostic Pathology Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Laboratory Diagnostic Services
TypeTransaction Fee
Description

Laboratory CIAP generates revenue through providing pathological anatomy and cytology diagnostic services. Services are delivered to private patients, through health insurance plans (convênios), and for SUS (public healthcare system) for hospitalized patients in the region. Revenue comes from examination fees, report issuance, and specialized diagnostic procedures.

laboratoriociap.com.br
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details3 tiers
1Private Patient Services
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Direct payment by private patients for diagnostic examinations and reports.

laboratoriociap.com.br
2Health Insurance (Convênios) Services
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Services billed through health insurance providers including Unimed, Bradesco Saúde, Cemig Saúde, and 17 other plans.

laboratoriociap.com.br
3SUS (Public Healthcare System)
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Services provided free of charge to patients hospitalized in regional hospitals through the Brazilian public healthcare system.

laboratoriociap.com.br
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Laboratório CIAP is a clinical pathology laboratory providing specialized diagnostic services including cytopathology, anatomical pathology, immunohistochemistry, in situ hybridization, intraoperative frozen section examination, and PCR-based HPV genotyping. The laboratory issues diagnostic reports for major healthcare centers and physicians across the Centro-Oeste region of Minas Gerais, supporting cancer and inflammatory disease diagnosis and treatment guidance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Early detection of precancerous conditions through cytology enables definitive cure when diagnosed in initial phases
+2 more records
Product overview1 text field

CIAP Laboratory is a specialized cytology and pathological anatomy laboratory offering a comprehensive portfolio of diagnostic services. The core services include Cytopathology (Pap smears), Pathological Anatomy (surgical specimens and biopsies), Immunohistochemistry, In Situ Hybridization (molecular pathology), and Frozen Section analysis (intraoperative diagnostics). The laboratory recently added HPV Genotyping by PCR as an advanced molecular offering. Services are provided by a team of specialist pathologists and are supported by quality certifications including ONA accreditation. Patients can access their diagnostic reports through an integrated external report viewing platform (Laudos Med).

Product and service6 records
1Citopatologia (Cytopathology)
CategoryDiagnostic service
Description

Cytopathology service that prevents gynecological cancer by identifying atypical cancerous or precancerous cells in smear samples. Designed for physicians, healthcare centers, and patients needing cancer screening examinations such as Papanicolau tests.

2Anatomia Patológica (Pathological Anatomy)
CategoryDiagnostic service
Description

Study of surgical specimens and biopsies to diagnose pathological processes and differentiate between benign and malignant tumors, providing guidance for treatment decisions. Used by surgeons, oncologists, and healthcare centers.

3Imuno-Histoquímica (Immunohistochemistry)
CategoryDiagnostic service
Description

Complex diagnostic procedure using specific antigens and antibodies to define malignant tumors, primary tumor sites, or histogenic differentiation. Used by oncologists and pathologists for tumor classification.

4Hibridização In Situ (In Situ Hybridization - HIS)
CategoryMolecular pathology service
Description

Innovative molecular pathology method identifying specific genetic alterations in altered cells. Used for viral infection diagnosis (HPV, Epstein-Barr virus), chromosomal damage analysis, genetic mapping, comparative genomics, and breast cancer diagnosis including HER2/neu verification. Targeted at oncologists and molecular diagnostics.

5Exame por Congelação (Frozen Section)
CategoryIntraoperative diagnostic service
Description

Immediate intraoperative procedure that allows physicians to obtain patient diagnosis during surgical intervention to define the most appropriate surgical approach. Used by surgeons and operating room teams.

6Genotipagem de HPV por PCR
CategoryAdvanced molecular diagnostic service
Description

Advanced molecular test using PCR in liquid-based cytology that identifies specific types of Human Papillomavirus, classifying them as high or low oncogenic risk. Detects up to 15 high-risk HPV genotypes including HPV 16 and 18, the main causes of cervical cancer. The same sample can be used for both traditional Papanicolau and HPV genotyping.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeOthers
Description

Professional association membership providing access to quality control programs (PICQ), continuing education, and professional standards in anatomical pathology. The laboratory's medical staff are specialists certified by SBP.

2Organização Nacional de Acreditação (ONA)
Strategic tierCoreTypeOthers
Description

ONA is the Brazilian organization responsible for certifying quality standards in healthcare services. CIAP maintains ONA accreditation with evaluation by DNV.

laboratoriociap.com.br
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Laboratory CIAP serves as the primary pathological anatomy diagnostic provider for major health centers in the Centro-Oeste region of Minas Gerais, providing diagnostic reports and clinical case discussions.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with 19 health insurance providers including Unimed, Bradesco Saúde, Cemig Saúde, and others for providing diagnostic services to insured patients.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with the Brazilian public healthcare system to provide free diagnostic services for hospitalized patients in regional hospitals.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers7 records
TypeBroad incumbent
Description

Brazil's largest diagnostic medicine company, operating a national network of labs and imaging centers with comprehensive anatomic pathology and cytology services. Comparable to CIAP as a pathology/diagnostic laboratory, but at vastly greater geographic scale and across multiple diagnostic modalities.

2Sabin Diagnósticos e Saúde
TypeBroad incumbent
Description

Brazilian diagnostic chain providing clinical analysis, anatomic pathology, and vaccination services across multiple states. Operates a broader diagnostic menu than CIAP but competes for the same hospital, convênio, and physician referral relationships.

TypeEmerging player
Description

Brazilian technology-enabled diagnostic platform offering remote clinical analysis and pathology services via digital workflows. Represents the technology-mediated competitive threat to traditional brick-and-mortar labs like CIAP, particularly in molecular and reference testing categories.

TypeBroad incumbent
Description

Major Brazilian medical diagnostic company offering anatomic pathology among a broad portfolio of clinical analysis and imaging services. Comparable as a multi-modality diagnostic player, though focused on São Paulo and metropolitan areas versus CIAP's regional Minas Gerais focus.

TypeBroad incumbent
Description

Large Brazilian diagnostic network offering anatomic pathology, molecular diagnostics, and reference lab services nationally. Comparable in pathology capabilities and molecular testing (including HPV) to CIAP, but at much larger scale and with broader geographic reach.

TypeDirect peer
Description

Brazilian diagnostic laboratory with specialization in anatomic pathology, cytopathology, and molecular diagnostics including HPV testing. Most direct functional comparator to CIAP given similar specialist focus on pathology over general clinical analysis.

TypeRegional player
Description

Brazilian diagnostic chain with a meaningful Minas Gerais footprint across clinical analysis and imaging. Comparable as a competitor for convênio contracts and physician referrals in CIAP's regional market, though broader in scope than CIAP's pathology specialization.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ciap Citologia E Anatomia Patologica

Diagnostic Pathology Serviceslaboratoriociap.com.br

Laboratório CIAP is a private clinical pathology laboratory in Divinópolis, Minas Gerais, Brazil, providing cytology, anatomical pathology, immunohistochemistry, in situ hybridization, frozen section, and HPV PCR genotyping to private patients, 19+ health insurers, and SUS across the Centro-Oeste region of Minas Gerais.

What Ciap Citologia E Anatomia Patologica does

Laboratório CIAP – Citologia e Anatomia Patológica is a private, founder-led clinical pathology laboratory headquartered in Divinópolis, Minas Gerais, Brazil. Founded in 2015, it operates as the principal reference laboratory for pathological anatomy and cytology in the Centro-Oeste region of Minas Gerais, serving private patients, patients covered by 19 health insurance plans (including Unimed, Bradesco Saúde, and Cemig Saúde), and hospitalized patients funded through the Brazilian public healthcare system (SUS). Services are delivered from a main location on Av. Getúlio Vargas in Divinópolis and a fixed collection point at Hospital São João de Deus.

The laboratory's diagnostic portfolio spans cytopathology (Papanicolau and oncotic cytology), anatomical pathology on surgical specimens and biopsies, immunohistochemistry for tumor classification, in situ hybridization (HIS) for viral detection (HPV, EBV), chromosomal damage analysis and HER2/neu verification, intraoperative frozen section for real-time surgical guidance, and — as of February 2025 — PCR-based HPV genotyping covering up to 15 high-risk genotypes from a single liquid-based sample compatible with the GynoPrep collection kit. Quality assurance is anchored by ONA "Acreditado" certification (evaluated by DNV under Brazilian Accreditation Manual Version 2018 and Norma NA 4), participation in the PICQ quality control program of the Sociedade Brasileira de Patologia, and SBP-certified specialist pathologists trained at UNIFESP, Hospital A.C. Camargo, and Sírio Libanês.

Revenue is generated on a fee-per-examination basis across the three payer channels (private, convênio, SUS), with pricing not publicly disclosed. Patient report delivery is handled through the third-party Laudos Med platform. The business is governed under a formal structure compliant with Brazil's LGPD, with a designated Data Protection Officer. There is no evidence of external investment, multi-site operations, or expansion beyond the Centro-Oeste region of Minas Gerais.

Ciap Citologia E Anatomia Patologica firmographics

Firmographics
Name
Ciap Citologia E Anatomia Patologica
Legal name
Laboratório CIAP – Citologia e Anatomia Patológica
Website
https://laboratoriociap.com.br
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Laboratório CIAP is a private clinical pathology laboratory in Divinópolis, Minas Gerais, Brazil, providing cytology, anatomical pathology, immunohistochemistry, in situ hybridization, frozen section, and HPV PCR genotyping to private patients, 19+ health insurers, and SUS across the Centro-Oeste region of Minas Gerais.
Ownership category
akta.pro rank

Ciap Citologia E Anatomia Patologica industry classification

Industry
Product category
Diagnostic Pathology Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

Keywords

  • Diagnostic pathology services
  • Cytopathology laboratory
  • Anatomical pathology
  • Immunohistochemistry testing
  • HPV genotyping PCR

Where Ciap Citologia E Anatomia Patologica is headquartered

Location

Headquarters

HQ city
Divinópolis
HQ country
Brazil
HQ region
Latin America

Offices2 records

Markets served

Ciap Citologia E Anatomia Patologica business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Laboratory Diagnostic Services: Laboratory CIAP generates revenue through providing pathological anatomy and cytology diagnostic services. Services are delivered to private patients, through health insurance plans (convênios), and for SUS (public healthcare system) for hospitalized patients in the region. Revenue comes from examination fees, report issuance, and specialized diagnostic procedures.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goPrivate Patient Services
Transaction based/ take ratePay-as-you-goHealth Insurance (Convênios) Services
Transaction based/ take ratePay-as-you-goSUS (Public Healthcare System)

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Ciap Citologia E Anatomia Patologica product offering

Product offering

Core offering

Laboratório CIAP is a clinical pathology laboratory providing specialized diagnostic services including cytopathology, anatomical pathology, immunohistochemistry, in situ hybridization, intraoperative frozen section examination, and PCR-based HPV genotyping. The laboratory issues diagnostic reports for major healthcare centers and physicians across the Centro-Oeste region of Minas Gerais, supporting cancer and inflammatory disease diagnosis and treatment guidance.

Product overview

CIAP Laboratory is a specialized cytology and pathological anatomy laboratory offering a comprehensive portfolio of diagnostic services. The core services include Cytopathology (Pap smears), Pathological Anatomy (surgical specimens and biopsies), Immunohistochemistry, In Situ Hybridization (molecular pathology), and Frozen Section analysis (intraoperative diagnostics). The laboratory recently added HPV Genotyping by PCR as an advanced molecular offering. Services are provided by a team of specialist pathologists and are supported by quality certifications including ONA accreditation. Patients can access their diagnostic reports through an integrated external report viewing platform (Laudos Med).

Differentiator

Problem solved

Functional benefit

Products and services

  • Citopatologia (Cytopathology) Cytopathology service that prevents gynecological cancer by identifying atypical cancerous or precancerous cells in smear samples. Designed for physicians, healthcare centers, and patients needing cancer screening examinations such as Papanicolau tests.
  • Anatomia Patológica (Pathological Anatomy) Study of surgical specimens and biopsies to diagnose pathological processes and differentiate between benign and malignant tumors, providing guidance for treatment decisions. Used by surgeons, oncologists, and healthcare centers.
  • Imuno-Histoquímica (Immunohistochemistry) Complex diagnostic procedure using specific antigens and antibodies to define malignant tumors, primary tumor sites, or histogenic differentiation. Used by oncologists and pathologists for tumor classification.
  • Hibridização In Situ (In Situ Hybridization - HIS) Innovative molecular pathology method identifying specific genetic alterations in altered cells. Used for viral infection diagnosis (HPV, Epstein-Barr virus), chromosomal damage analysis, genetic mapping, comparative genomics, and breast cancer diagnosis including HER2/neu verification. Targeted at oncologists and molecular diagnostics.
  • Exame por Congelação (Frozen Section) Immediate intraoperative procedure that allows physicians to obtain patient diagnosis during surgical intervention to define the most appropriate surgical approach. Used by surgeons and operating room teams.
  • Genotipagem de HPV por PCR Advanced molecular test using PCR in liquid-based cytology that identifies specific types of Human Papillomavirus, classifying them as high or low oncogenic risk. Detects up to 15 high-risk HPV genotypes including HPV 16 and 18, the main causes of cervical cancer. The same sample can be used for both traditional Papanicolau and HPV genotyping.

Quantifiable outcome

  • Early detection of precancerous conditions through cytology enables definitive cure when diagnosed in initial phases
  • +2 more outcomes

Companies that use Ciap Citologia E Anatomia Patologica

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Ciap Citologia E Anatomia Patologica technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature7 records

Ciap Citologia E Anatomia Patologica partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • Sociedade Brasileira de Patologia (SBP)coreOthersProfessional association membership providing access to quality control programs (PICQ), continuing education, and professional standards in anatomical pathology. The laboratory's medical staff are specialists certified by SBP.
  • Organização Nacional de Acreditação (ONA)coreOthersONA is the Brazilian organization responsible for certifying quality standards in healthcare services. CIAP maintains ONA accreditation with evaluation by DNV.
  • Regional Healthcare CenterscoreStrategic or Co-development PartnerLaboratory CIAP serves as the primary pathological anatomy diagnostic provider for major health centers in the Centro-Oeste region of Minas Gerais, providing diagnostic reports and clinical case discussions.
  • Health Insurance Providers (Convênios)coreChannel Partner/ Reseller/ DistributorPartnership with 19 health insurance providers including Unimed, Bradesco Saúde, Cemig Saúde, and others for providing diagnostic services to insured patients.
  • SUS (Sistema Único de Saúde)coreChannel Partner/ Reseller/ DistributorPartnership with the Brazilian public healthcare system to provide free diagnostic services for hospitalized patients in regional hospitals.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Ciap Citologia E Anatomia Patologica competitors and assessment

Company assessment

Broad incumbents

  • DASA (Diagnósticos da América): Brazil's largest diagnostic medicine company, operating a national network of labs and imaging centers with comprehensive anatomic pathology and cytology services. Comparable to CIAP as a pathology/diagnostic laboratory, but at vastly greater geographic scale and across multiple diagnostic modalities.
  • Sabin Diagnósticos e Saúde: Brazilian diagnostic chain providing clinical analysis, anatomic pathology, and vaccination services across multiple states. Operates a broader diagnostic menu than CIAP but competes for the same hospital, convênio, and physician referral relationships.
  • Fleury Medicina e Saúde: Major Brazilian medical diagnostic company offering anatomic pathology among a broad portfolio of clinical analysis and imaging services. Comparable as a multi-modality diagnostic player, though focused on São Paulo and metropolitan areas versus CIAP's regional Minas Gerais focus.
  • Hermes Pardini (Grupo Pardini): Large Brazilian diagnostic network offering anatomic pathology, molecular diagnostics, and reference lab services nationally. Comparable in pathology capabilities and molecular testing (including HPV) to CIAP, but at much larger scale and with broader geographic reach.

Emerging players

  • Hilab: Brazilian technology-enabled diagnostic platform offering remote clinical analysis and pathology services via digital workflows. Represents the technology-mediated competitive threat to traditional brick-and-mortar labs like CIAP, particularly in molecular and reference testing categories.

Direct peers

  • Centro de Patologia Clinica (CPC): Brazilian diagnostic laboratory with specialization in anatomic pathology, cytopathology, and molecular diagnostics including HPV testing. Most direct functional comparator to CIAP given similar specialist focus on pathology over general clinical analysis.

Regional players

  • Alliança Saúde e Diagnóstico: Brazilian diagnostic chain with a meaningful Minas Gerais footprint across clinical analysis and imaging. Comparable as a competitor for convênio contracts and physician referrals in CIAP's regional market, though broader in scope than CIAP's pathology specialization.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Ciap Citologia E Anatomia Patologica social profiles

Digital presence

Ciap Citologia E Anatomia Patologica compliance and trust

Trust signal

Compliance4 records

Ciap Citologia E Anatomia Patologica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ciap Citologia E Anatomia Patologica leadership team

Management profile

Number of profiles

Profiles3 records

Ciap Citologia E Anatomia Patologica funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ciap Citologia E Anatomia Patologica M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ciap Citologia E Anatomia Patologica

What does Ciap Citologia E Anatomia Patologica do?

Laboratório CIAP is a clinical pathology laboratory providing specialized diagnostic services including cytopathology, anatomical pathology, immunohistochemistry, in situ hybridization, intraoperative frozen section examination, and PCR-based HPV genotyping. The laboratory issues diagnostic reports for major healthcare centers and physicians across the Centro-Oeste region of Minas Gerais, supporting cancer and inflammatory disease diagnosis and treatment guidance.

Is Ciap Citologia E Anatomia Patologica a public or private company?

Ciap Citologia E Anatomia Patologica is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Ciap Citologia E Anatomia Patologica founded?

Ciap Citologia E Anatomia Patologica was founded in 2015. It employs 11 to 50 people.

Where is Ciap Citologia E Anatomia Patologica based?

Ciap Citologia E Anatomia Patologica is headquartered in Divinópolis, Brazil, in the Latin America region.

How does Ciap Citologia E Anatomia Patologica make money?

One revenue line is on record: laboratory Diagnostic Services.

Who are Ciap Citologia E Anatomia Patologica's main competitors?

Broad incumbents on record are DASA (Diagnósticos da América), Sabin Diagnósticos e Saúde, Fleury Medicina e Saúde and Hermes Pardini (Grupo Pardini). Hilab is listed as an emerging player. Centro de Patologia Clinica (CPC) is listed as a direct peer. Alliança Saúde e Diagnóstico is listed as a regional player.

Does Ciap Citologia E Anatomia Patologica have an API?

No public API is recorded for Ciap Citologia E Anatomia Patologica.

What industry is Ciap Citologia E Anatomia Patologica in?

Ciap Citologia E Anatomia Patologica's product category is Diagnostic Pathology Services. Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales